<DOC>
	<DOCNO>NCT00234338</DOCNO>
	<brief_summary>The purpose study estimate local systemic tolerability Prevenar child age 2 5 year old usual care setting .</brief_summary>
	<brief_title>Study Evaluating Prevenar High-Risk Children</brief_title>
	<detailed_description />
	<mesh_term>Pneumococcal Infections</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Highrisk child age 2 5 year old Exclusion criterion : Prior administration Prevenar Prior and/or concurrent administration 23 vPs vaccine</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>5 Years</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>Children</keyword>
	<keyword>Vaccine</keyword>
	<keyword>Prevenar</keyword>
</DOC>